Logo

Invitrogen Opens Gateway for NHGRI and NCI

May 05, 2004

NEW YORK, May 5 (GenomeWeb News) - Invitrogen yesterday announced an agreement with the National Human Genome Research Institute and the National Cancer Institute to institute open access to the company's Gateway and SuperScript technologies for use with the Mammalian Gene Collection program.

 

Gateway is a method for cloning DNA sequences for functional study. Additionally, some Gateway vectors allow for the synthesis of protein products. Under Invitrogen's licensing policies, academic and government researchers can create and distribute Gateway clones and expression clones to any entity without royalties or licensing fees.

 

The Mammalian Gene Collection program is an NIH-funded effort to generated sequenced full-length cDNAs.

 

Breaking News
The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.